Sign In
Buy NDAQ
$77.65
-3.96 (-4.85%)
At Close: Jun 25, 2026
Nasdaq poised to jump as chip maker TSMC inspires gains in Nvidia, AMD
08:32am, Thursday, 17'th Oct 2024
Nasdaq-listed tech stocks are poised to drive a positive open on Wall Street on Thursday, following encouraging reports from the semiconductor industry. Futures for the Nasdaq 100 were up almost 0.
Nasdaq Composite Today: TSM Leads Another AI Stock Frenzy (TSM, NVDA, AVGO)
08:07am, Thursday, 17'th Oct 2024
Shortly before 8 a.m. ET markets are looking up across the board on Thursday.
Lixiang Education Regains Compliance with Nasdaq Minimum Bid Price Requirement
06:00am, Thursday, 17'th Oct 2024
LISHUI, China, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Lixiang Education Holding Co., Ltd. (the “Company” or NASDAQ: LXEH), a prestigious private education service provider in China, today announced tha
Nasdaq Integrates AI to Simplify and Accelerate Bank and Insurance Risk Calculations
03:00am, Thursday, 17'th Oct 2024
Market volatility and regulatory requirements are driving increasingly complex and computationally intensive risk calculations
Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Wednesday, 16'th Oct 2024
YARDLEY, Pa., Oct. 16, 2024 (GLOBE NEWSWIRE) -- OptiNose, Inc. (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announce
Direct Digital Holdings Regains Nasdaq Compliance
04:01pm, Wednesday, 16'th Oct 2024
HOUSTON , Oct. 16, 2024 /PRNewswire/ -- Direct Digital Holdings, Inc. (Nasdaq: DRCT) ("Direct Digital Holdings" or the "Company"), a leading advertising and marketing technology platform operating thr
Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:00pm, Wednesday, 16'th Oct 2024
WATERTOWN, Mass., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage precision medicine company utilizing its A
Lexaria Announces Closing of $5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
04:00pm, Wednesday, 16'th Oct 2024
KELOWNA, BC / ACCESSWIRE / October 16, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX; LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced that it has clo
Wrap Technologies, Inc. Regains Nasdaq Listing Requirements Compliance
09:05am, Wednesday, 16'th Oct 2024
TEMPE, Ariz., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Wrap Technologies, Inc. (NASDAQ: WRAP) (the “Company”), a global leader in innovative public safety solutions, announced today that it received writ
Wednesday Market News: Nasdaq Composite and S&P Futures Up Slightly (J
08:21am, Wednesday, 16'th Oct 2024
As of 8 a.m. ET, indexes are slightly in the green in premarket trading.
VANCOUVER, British Columbia, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Versus Systems, Inc. (NASDAQ: VS) (the “Company”) announced today the execution of two significant agreements with Aspis Cyber Techno
authID Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06:00pm, Tuesday, 15'th Oct 2024
Denver, Oct. 15, 2024 (GLOBE NEWSWIRE) -- authID Inc. (Nasdaq: AUID), a leading provider of secure identity verification and authentication solutions, today announced that the Compensation Committee
Nasdaq leads stock declines as Nvidia, chip stocks sell off
05:48pm, Tuesday, 15'th Oct 2024
To get the latest market news check out finance.yahoo.com US stocks closed lower on Tuesday as investors reacted to downbeat earnings from ASML Holding (ASML) that dropped a day earlier than expected,
Ribbon Communications Announces Inducement Equity Grants to John Townsend Under Nasdaq Listing Rule 5635(c)(4)
05:30pm, Tuesday, 15'th Oct 2024
PLANO, Texas , Oct. 15, 2024 /PRNewswire/ -- Ribbon Communications Inc. (Nasdaq: RBBN), a global provider of real time communications technology and IP optical networking solutions to many of the worl
Biodexa Announces Successful Appeal of Nasdaq Delisting
04:15pm, Tuesday, 15'th Oct 2024
Exhibit 99.1 October 15, 2024 Biodexa Announces Successful Appeal of Nasdaq Delisting Biodexa Pharmaceuticals PLC. (the “Company”) (Nasdaq: BDRX), an acquisition-focused clinical stage biopharmace
